Jonathan Rosman, MD
Clinical Cardiac Electrophysiology · Boca Raton, FLNPI 1497905269
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 47.7% of the total. Reporting peaked in 2021 at $5,499 and has fallen 85.2% since, to $815 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 215 payments — averaging $49.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$5K
- Medtronic$2K
- Biosense Webster, Inc.$2K
- Abbott$1K
- Impulse Dynamics (USA) Inc.$257
- Medical Device Business Services, Inc.$195
- plus $742 from 10 others
Across 25 payments — averaging $4043.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$101K
- Medtronic$475
What the payments were for
- Speaking & faculty fees$4,50042%
- Food & beverage$6,15858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 24 | $5,085 |
| Medtronic(2 entities) | 51 | $1,748 |
| Biosense Webster, Inc. | 59 | $1,581 |
| Abbott | 34 | $1,049 |
| Impulse Dynamics (USA) Inc. | 2 | $257 |
| Medical Device Business Services, Inc. | 6 | $195 |
| Johnson & Johnson | 10 | $189 |
| Cardiva Medical, Inc. | 9 | $169 |
| Sanofi-aventis U.S. LLC | 4 | $125 |
| Boston Scientific | 6 | $108 |
| Cvrx, Inc. | 3 | $44 |
| Baxter Healthcare | 2 | $30 |
| Acutus Medical, Inc. | 2 | $26 |
| Pfizer | 1 | $21 |
| Philips North America LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$4,600
- OPTIMIZER$348
- Micra$185
- Carto 3$147
- Advisa$120
- AZURE XT DR MRI SURESCAN$114
- Carto 3 System$100
How this compares
$10,658 in reported general payments places this provider in the 25th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 317 | $281,247 |
| MultaqDronedarone Hcl | 190 | $265,600 |
| XareltoRivaroxaban | 157 | $164,460 |
| Droxidopa | 15 | $96,419 |
| Disopyramide Phosphate | 76 | $13,666 |
| Flecainide Acetate | 147 | $6,636 |
| Metoprolol Succinate | 263 | $4,163 |
| Mexiletine Hcl | 19 | $2,239 |
| Dofetilide | 23 | $2,234 |
| Propafenone Hcl ErPropafenone Hcl | 12 | $2,226 |
| Amiodarone Hcl | 65 | $1,407 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $1,304 |
| Verapamil ErVerapamil Hcl | 52 | $1,126 |
| SotalolSotalol Hcl | 47 | $730 |
| Bisoprolol Fumarate | 16 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $21 | $281,247317 claims |
| Sanofi-aventis U.S. LLCMultaq | $125 | $265,600190 claims |
| Johnson & JohnsonXarelto | $189 | $164,460157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Boca Raton
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
- Marcelo JimenezAtlantis$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.